Patent ID: 7943650

Claim:
A method of treating and/or mitigating prostate cancer, ovarian cancer, melanoma, colorectal cancer, breast cancer or lung cancer, comprising administering to an individual in need thereof a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound of formula (I): where T is phenyl optionally substituted with alkyl, perfluoroalkyl, alkyloxy, alkenyl, alkynyl, cycloalkyl, aryl, aryloxy, arylalkyl, mercaptoalkyl, or a moiety selected from the group consisting of F, Cl, Br, I, OH, SH, CN, NR 8 R 9 , NO 2 , CO 2 R 10 and CHO, wherein R 8 , R 9 and R 10 are unsubstituted and are independently hydrogen, alkyl, perfluoroalkyl, alkyloxy, alkenyl, alkynyl, cycloalkyl, aryl, aryloxy, arylalkyl or mercaptoalkyl; n is 1 to 6: C represents carbon, at least one C of (C) n is substituted with a ring structure selected from the group consisting of 1,3-dioxolanyl, 1,3-dioxanyl, 1,3-dithiolanyl, and 1,3-dithianyl, wherein the C is optionally contained as part of the ring structure, the ring structure optionally substituted with the group: where e and f are independently 0, 1, 2, 3, 4, 5, or 6; L is O, CR 19 R 20 , OSO 2 , SO, OSO, NR 21 , NHCO, CONH, OCO, COO, CO, OP(O)(OR)O, or OP(OR)O, wherein R is hydrogen, alkyl, aryl, or arylalkyl; Z, R 6 , R 7 , R 19 , R 20 and R 21 are independently hydrogen, alkyl, perfluoroalkyl, alkyloxy, alkenyl, alkynyl, cycloalkyl, aryl, aryloxy, arylalkyl, mercaptoalkyl, or a moiety selected from the group consisting of F, Cl, Br, I, OH, SH, CN, NR 8 R 9 , NO 2 , CO 2 R 10 and CHO, wherein R 8 , R 9 and R 10 are as defined above, wherein Z is optionally substituted with alkyl, perfluoroalkyl, alkyloxy, alkenyl, alkynyl, cycloalkyl, aryl, aryloxy, arylalkyl, mercaptoalkyl, or a moiety selected from the group consisting of F, Cl, Br, I, OH, SH, CN, NR 8 R 9 , NO 2 , CO 2 R 10 and CHO, wherein R 8 , R 9 and R 10 are as defined above; and D is imidazolyl; or a pharmaceutically acceptable salt or ester of said compound.